Bloomberg Markets & Finance via Youtube

Sep.21 — A report by Goldman Sachs Group Inc. strategists, led by David Kostin, says value shares are a better way to bet on a Covid-19 vaccine than cyclical stocks, even though the latter have gained favor for capturing the trade. Juliette Saly reports on “Bloomberg Daybreak: Europe.”

READ ALSO  Global COVID-19 Cases Top 500,000 In A Day For First Time: Live Updates